Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
There is a significant demand for exploring new treatment options and identifying potential biomarkers that can indicate the therapeutic response to antidepressant treatment. Depression frequently coexists with metabolic syndrome, and there may be a pathophysiological overlap between the two, which could include changes in the microbiota ().
It is a randomized, clinical phase III treatment trial studying Bifidobacterium longum Rosell-175 (TM-175/R-175) + Lactobacillus helveticus Rosell-52 (R0052/TM-52) or placebo in 95 adult patients (analyze…